Advertisement

International Journal of Clinical Pharmacy

, Volume 34, Issue 2, pp 351–357 | Cite as

Pharmacist proactive medication recommendations using electronic documentation in a UK general critical care unit

  • Richard S. BourneEmail author
  • Chui Lynn Choo
Research Article

Abstract

Background Specific data on the actual clinical practice of United Kingdom pharmacists in Critical Care are limited. Within the general critical care units of Sheffield Teaching Hospitals, clinical pharmacists have the facility to electronically document, communicate and follow-up proactive recommendations using a Pharmacy Review Form via the Clinical Information System, MetaVision®. Objective The objective of the service evaluation was to describe the acceptance rate by medical staff of pharmacist proactive medication recommendations; including data on the types of recommendations and reasons thereof, for general intensive care patients of a UK teaching hospital trust. Setting Sheffield Teaching Hospitals National Health Service Foundation Trust with 20 intensive care beds located on two hospital sites admitting Level 3 and 2 mixed general medical, surgical, trauma, burns and haematology/ oncology patients. Method Retrospective analysis of pharmacist proactive recommendations recorded electronically from January 2009 to July 2011 in general intensive care unit patients. Main outcome 5,623 electronic medication recommendations were documented, providing an average of 2.2 proactive recommendations per patient admitted to intensive care from January 2009 to July 2011. 5,101 (90.7%) of the recommendations were accepted and acted upon by medical staff. Results The most common recommendations were Add Drug 1,862 (28.2%); Dose Review 1,707 (25.8%); Discontinue Drug 1,185 (17.9%); Alternative Drug 903 (13.7%); Alternative Route 770 (11.7%). The most common reasons for the proactive medication recommendations were related to changes in gastrointestinal absorption 951 (15.6%); compliance with medication guidelines 857 (14.1%); sedation/delirium/agitation management 764 (12.6%); dose adjustment for renal dysfunction or continuous renal replacement therapies 756 (12.4%); and medication reconciliation 612 (10.1%). The majority of medication recommendations involved drugs in Gastrointestinal, Central Nervous System, Cardiovascular, Infection, Nutrition and Blood classes (British National Formulary). Conclusion There was a high acceptance rate for proactive medication-related recommendations made by critical care pharmacists via the electronic review form. The majority of pharmacist recommendations were related to adding or refining currently prescribed medication. Ten percent of recommendations related to medication reconciliation of patients’ pre-admission medication.

Keywords

Clinical pharmacist Critical care Drug therapy Medicines reconciliation United Kingdom 

Notes

Acknowledgments

We are grateful to Dr Mike Heap for his continued support with the customisation of the pharmacy review form and ongoing report generation. We are indebted to the pharmacist and medical staff for their support and use of the form in their clinical practice.

Funding

No special funding obtained.

Conflicts of interest

The authors claim no conflicts of interest.

References

  1. 1.
    Valentin A, Capuzzo M, Guidet B, Moreno R, Metnitz B, Bauer P, et al. Errors in administration of parenteral drugs in intensive care units: multinational prospective study. BMJ. 2009;338:b814.PubMedCrossRefGoogle Scholar
  2. 2.
    Kopp BJ, Mrsan M, Erstad BL, Duby JJ. Cost implications of and potential adverse events prevented by interventions of a critical care pharmacist. Am J Health Syst Pharm. 2007;64:2483–7.PubMedCrossRefGoogle Scholar
  3. 3.
    MacLaren R, Bond C, Martin S, Fike D. Clinical and economic outcomes of involving pharmacists in the direct care of critically ill patients with infections. Crit Care Med. 2008;36:3184.PubMedCrossRefGoogle Scholar
  4. 4.
    Klopotowska J, Kuiper R, van Kan H, de Pont AC, Dijkgraaf M, Lie-A-Huen L, et al. On-ward participation of a hospital pharmacist in a Dutch intensive care unit reduces prescribing errors and related patient harm: an intervention study. Crit Care. 2010;14:R174.PubMedCrossRefGoogle Scholar
  5. 5.
    LeBlanc JM, Seoane-Vazquez EC, Arbo TC, Dasta JF. International critical care hospital pharmacist activities. Intensive Care Med. 2008;34:538–42.PubMedCrossRefGoogle Scholar
  6. 6.
    Zaidi ST, Hassan Y, Postma MJ, Ng SH. Impact of pharmacist recommendations on the cost of drug therapy in ICU patients at a Malaysian hospital. Pharm World Sci. 2003;25:299–302.PubMedCrossRefGoogle Scholar
  7. 7.
    Al-Jazairi AS, Al-Agil AA, Asiri YA, Al-Kholi TA, Akhras NS, Horanieh BK. The impact of clinical pharmacist in a cardiac-surgery intensive care unit. Saudi Med J. 2008;29:277–81.PubMedGoogle Scholar
  8. 8.
    Mckenzie C, Yassin S, Terblanche M. Sedation and analgesia: early results from a web-based survey of UK practice. Crit Care. 2010;14(Suppl 1):P490.CrossRefGoogle Scholar
  9. 9.
    Devlin JW, Holbrook AM, Fuller HD. The effect of ICU sedation guidelines and pharmacist interventions on clinical outcomes and drug cost. Ann Pharmacother. 1997;31:689–95.PubMedGoogle Scholar
  10. 10.
    Ibrahim EH, Kollef MH. Using protocols to improve the outcomes of mechanically ventilated patients: focus on weaning and sedation. Crit Care Clin. 2001;17:989–1001.PubMedCrossRefGoogle Scholar
  11. 11.
    Devlin JW, Nasraway SA Jr. Reversing oversedation in the intensive care unit: the role of pharmacists in energizing guideline efforts and overcoming protocol fatigue. Crit Care Med. 2008;36:626–8.PubMedCrossRefGoogle Scholar
  12. 12.
    Churchwell MD, Mueller BA. The clinical application of CRRT—current status: drug dosing during continuous renal replacement therapy. In: Seminars in dialysis. Wiley Online Library; 2009. p. 185–188.Google Scholar
  13. 13.
    Technical patient safety solutions for medicines reconciliation on admission of adults to hospital: Guidance: National Institute for Health and Clinical Excellence and National Patient Safety Agency, 2007. Available from the world-wide-web: www.nice.org.uk/nicemedia/pdf/PSG001Guidance.pdf.
  14. 14.
    Dodds LJ. Unintended discrepancies between pre-admission and admission prescriptions identified by pharmacy-led medicines reconciliation: results of a collaborative service evaluation across East and SE England. Int J Phar Pract. 2010;18(Suppl 2):9–10.Google Scholar
  15. 15.
    Surviving Sepsis Campaign. Available from the world-wide-web. www.survivingsepsis.org/Bundles/Individual_Changes/Pages/improve_antibiotic_time.aspx.
  16. 16.
    Ibrahim KH, Gunderson B, Rotschafer JC. Intensive care unit antimicrobial resistance and the role of the pharmacist. Crit Care Med. 2001;29:N108–13.PubMedCrossRefGoogle Scholar
  17. 17.
    Staples A, Dade J, Acomb C. Intravenous fluid therapy—what pharmacists need to monitor. Hospital Pharmacist. 2008;15:277.Google Scholar
  18. 18.
    Broyles JE, Brown RO, Vehe KL, Nolly RJ, Luther RW. Pharmacist interventions improve fluid balance in fluid-restricted patients requiring parenteral nutrition. Drug Intell Clin Phar. 1991;25:119–22.Google Scholar
  19. 19.
    Critical care syllabus: Foundation and excellence level: United Kingdom Clinical Pharmacy Association Critical Care Group, 2009. Available from the world-wide-web. www.ukcpa.org/docs/Critical%20Care%20Syllabus%202009.pdf.
  20. 20.
    Ng TM, Bell AM, Hong C, Hara JM, Touchette DR, Danskey KN, et al. Pharmacist monitoring of QTc interval-prolonging medications in critically Ill medical patients: a pilot study. Ann Pharmacother. 2008;42:475–82.PubMedCrossRefGoogle Scholar
  21. 21.
    Bourne RS, Dorward BJ. Clinical pharmacist interventions on a UK neurosurgical critical care unit: a 2-week service evaluation. Int J Clin Pharm. 2011;33:755–8.PubMedCrossRefGoogle Scholar
  22. 22.
    Barber ND, Batty R, Ridout DA. Predicting the rate of physician-accepted interventions by hospital pharmacists in the United Kingdom. Am J Health Syst Pharm. 1997;54:397–405.PubMedGoogle Scholar
  23. 23.
    Simonian A. Documenting pharmacist interventions on an intranet. Am J Health Syst Pharm. 2003;60:151–5.PubMedGoogle Scholar
  24. 24.
    Ammenwerth E, Iller C, Mahler C. IT-adoption and the interaction of task, technology and individuals: a fit framework and a case study. BMC Med Inform Decision Making. 2006;6:3.CrossRefGoogle Scholar
  25. 25.
    Choo CL. Service evaluation of the use of a clinical information system to document and communicate pharmacist-initiated medication recommendations in general intensive care units of Sheffield Teaching Hospitals. MSc. Leeds: University of Leeds; 2009.Google Scholar
  26. 26.
    Hartmann M, Meier-Hellmann A. How to increase return on investment of the intensive care pharmacist—fear of flying. Intensive Care Med. 2006;32:511–5.PubMedCrossRefGoogle Scholar
  27. 27.
    Patel G, Loh-Trivedi M. Clinical pharmacists in the intensive care unit: is there really an equation? Intensive Care Med. 2006;32:1275–6.PubMedCrossRefGoogle Scholar
  28. 28.
    Morrison C, Jones M, Blackwell A, Vuylsteke A. Electronic patient record use during ward rounds: a qualitative study of interaction between medical staff. Crit Care. 2008;12:R148.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2012

Authors and Affiliations

  1. 1.Departments of Pharmacy and Critical CareSheffield Teaching Hospitals, Northern General HospitalSheffieldUK
  2. 2.Department of PharmacyJohn Hunter HospitalNewcastleAustralia

Personalised recommendations